Sarah Barkow PhD AstraZeneca

Sarah Barkow, Ph.D., is the Senior Director of Proactive Compliance & Innovation at AstraZeneca. In this role, she spearheads initiatives to enhance regulatory compliance and drive innovative solutions as part of Global Quality Audit, leveraging the team’s experience. Sarah owns the inspection process at AZ and leads both the GMP/GDP regulatory intelligence process and external engagement strategy. Prior to AstraZeneca, Sarah was the Director of GxP External Engagement at Bristol Myers Squibb, working closely with PhRMA, BIO, IFPMA and other trade organizations and tracking regulatory and policy developments across the GxP realm. Sarah joined BMS from FDA, where she served as a Senior Advisor and Acting Director at the FDA’s Office of Compliance. Her contributions include drafting key guidance and policy documents, as well as inspectional compliance programs and warning letters. She also has a background in immunoassay development from Beckman Coulter. Sarah holds a Ph.D. in Physical Chemistry from MIT where she researched molecular motors.